uniQure N.V. QURE
$48.62
+3.31%
at last close
Analyst Consensus
- Consensus Rating
- Buy (10 Buy · 3 Hold · 0 Sell)
- Average Price Target
- $58.67
- Implied Upside
- +20.7%
- Price Target Range
- $9.00 – $95.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-30 | Wells FargoYanan Zhu |
Maintains | Overweight | $60 → $75 |
| 2026-07-30 | Wolfe ResearchRudy Li |
Upgrades | Peer perform → Outperform | $65 |
| 2026-07-30 | BarclaysEliana Merle |
Maintains | Overweight | $65 → $60 |
| 2026-06-29 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $50 → $80 |
| 2026-06-25 | MizuhoUy Ear |
Maintains | Outperform | $35 → $68 |
| 2026-06-18 | BarclaysEliana Merle |
Upgrades | Equal-weight → Overweight | $25 → $65 |
| 2026-06-18 | Goldman SachsSalveen Richter |
Maintains | Neutral | $14 → $46 |
| 2026-06-18 | Leerink PartnersJoseph Schwartz |
Maintains | Outperform | $36 → $70 |
| 2026-06-18 | RBC CapitalLuca Issi |
Maintains | Outperform | $35 → $65 |
| 2026-05-06 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $70 → $50 |
| 2026-04-20 | Goldman SachsSalveen Richter |
Maintains | Neutral | $9 → $10 |
| 2026-03-23 | BarclaysEliana Merle |
Maintains | Equal-weight | $31 → $25 |
| 2026-03-11 | MizuhoUy Ear |
Upgrades | Neutral → Outperform | $12 → $35 |
| 2026-03-10 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $70 |
| 2026-03-09 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $16 → $31 |
| 2026-03-09 | RBC CapitalLuca Issi |
Upgrades | Sector perform → Outperform | $11 → $35 |
| 2026-03-09 | Wells FargoYanan Zhu |
Upgrades | Equal-weight → Overweight | $15 → $60 |
| 2026-03-03 | Goldman SachsSalveen Richter |
Maintains | Neutral | $37 → $9 |
| 2026-03-03 | Wells FargoYanan Zhu |
Downgrades | Overweight → Equal-weight | $60 → $15 |
| 2026-03-03 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $53 → $16 |
| 2026-03-03 | MizuhoUy Ear |
Downgrades | Outperform → Neutral | $33 → $12 |
| 2026-03-02 | Cantor FitzgeraldKristen Kluska |
Upgrades | Overweight → Neutral | $55 → $9 |
| 2026-02-24 | Wolfe ResearchRudy Li |
Initiates coverage on | Peer perform | — |
| 2026-02-10 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $70 |
| 2026-01-28 | BarclaysEliana Merle |
Initiates coverage on | Equal-weight | $31 |
| 2025-12-11 | StifelPaul Matteis |
Maintains | Buy | $50 → $40 |
| 2025-12-09 | MizuhoUy Ear |
Maintains | Outperform | $60 → $33 |
| 2025-12-04 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $53 |
| 2025-11-12 | Wells FargoYanan Zhu |
Maintains | Overweight | $80 → $60 |
| 2025-11-11 | Chardan CapitalDaniil Gataulin |
Maintains | Buy | $53 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $48.62
- Market Cap
- $3.13 billion
- 52-Week Range
- $8.73 – $71.50
- Average Volume
- 1.38 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.